ERIC J. GILBERT,MICHAEL W. MILLER,JACK D. SCOTT,DUANE EUGENE DEMONG,ANDREW STAMFORD,WILLIAM J. GREENLEE,CHANDER SHEKHER CELLY
申请号：
BRPI0814806
公开号：
BRPI0814806A2
申请日:
2008.06.25
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
Compounds of Formula (I): or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB, receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
